Nippon Life India Asset Management's Q2FY24 Financial Performance Review

In this financial performance review, we delve into the results of Nippon Life India Asset Management for Q2FY24 and analyze key metrics, including revenue, expenses, net profit, and margin.

 

ParticularsQ2FY23YoY (% change)Q1FY24QoQ (% change)Q2FY24
Total Income (₹crs.)382.7914.96434.661.24440.05
Expenses (₹crs.)127.999.68140.030.25140.38
Net Profit (₹crs.)196.5519.64222.455.71235.16
Margin (%)51.352.0951.182.2653.44

 

REVENUE: 
The company reported a total income of ₹440.05 crores for Q2FY24, showing a modest 1.24% increase sequentially. On a year-on-year basis, the company demonstrated a robust 14.96% growth in total income compared to Q2FY23.

 

EXPENSES: 
Expenses for Nippon Asset Management in Q2FY24 amounted to ₹140.38 crores, reflecting a moderate 0.25% increase compared to the preceding quarter. On a year-on-year basis, expenses showed an rise of 9.68%. 

 

NET PROFIT: 
The net profit of Nippon Asset Management for Q2FY24 was ₹235.16 crores, showing a healthy 5.71% increase compared to Q1FY24. On a year-on-year basis, the company experienced an impressive growth of 19.64%, indicating strong profitability in its fund management activities.

 

MARGINS: 
Nippon Asset Management's margin in Q2FY24 reached 53.44%, reflecting a solid 2.26% increase compared to the preceding quarter. Year-on-year, the company's margin demonstrated a growth of 2.09%. The company's margins are in a healthy state, underlining its effective management of income and expenses.

 

In conclusion, Nippon Asset Management's financial performance in Q2FY24 reflects steady growth in revenue, profitability, and margins. Investors and stakeholders should keep a close watch on the company's cost management strategies and its ability to sustain the momentum in the coming quarters. 

 

Stay tuned for more updates on Nippon Asset Management's financial performance in the future.

Top stories
Company

Delta Corp Q1 PAT Declines 68% YoY to Rs 22 crore in FY25

4 mins read . 13 Jul 2024 . 09:30 AM

Company

Zydus Life Gets USFDA Nod for Heart Failure Drug

3 mins read . 13 Jul 2024 . 09:23 AM

Company

RVNL Spurts 10% on Bagging Multiple Orders Worth Rs 390 Cr

4 mins read . 13 Jul 2024 . 09:18 AM

Related Blogs
blog-logo

Share Market

blog-logo

12 mins read . 12 Jul 2024

Ritesh Agarwal: The OYO Founder’s Success Story

  • 0 people read
blog-logo

Share Market

blog-logo

15 mins read . 08 Jul 2024

Best Oil & Gas Stocks in India

  • 0 people read
Kickstart your equities journey today You've got this
By submitting this I agree to the terms & conditions